Find out how the Sickle Cell Society's successful partnership work with the NHS Sickle Cell and Thalassaemia Screening Programme makes a difference to the lives of people who live with sickle cell disorders and their families.
John James OBE
John James has 33 years of experience within the NHS including 4 chief executive officer roles. He was Chair of the West London Cancer network (2002 to 2005) and Chair of the North West London Diabetes Network (2003 to 2004). As a senior civil servant for the Department of Health he served as program consultant on leadership for the NHS Next Stage Review and then as Deputy Director for the NHS Medical Director/Director General. He has been Chief Executive of the Sickle Cell Society for the last 5 years. In June 2018, John was awarded an OBE as part of the Queen’s Birthday Honours.
Related content and links
PHE Screening has paused its social media accounts while staff support the national response to Covid-19.
Any queries in relation to the provision of screening programmes during the COVID-19 response can be made to the NHSEI Incident Control Team.
The PHE Screening team
Public Health England (PHE) is the expert voice on screening, providing advice and guidance to the NHS. The national population screening programmes identify apparently healthy people who may be at increased risk of a disease or condition, enabling earlier treatment and informed decisions.
Find out more about PHE Screening and this blog.
Watch our 44 second video for an overview of how the blog works.